Patient Advocates Continue To Push US FDA For Central Office

Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?

FDA entrance sign 2016
FDA had no update on the status of its Office of Patient Affairs proposal.

More from Rare Diseases

More from Pink Sheet